NCT05587257Status unknown
Role of Minoxidil in Alopecia Areata Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia Areata
Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia Areata
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Status unknown
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Assiut University
- Participants (registry)
- 60
- Start
- January 2023
- Primary completion
- January 2024
- Study completion
- February 2024
- Last registry update
- October 2022
- Countries
- —
Conditions studied: Alopecia Areata
Interventions: Fractional CO2 laser, Drug, Derma pen, Drug, Niosome minoxidil, Minoxidil Topical Spray
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.